Who owns NERV?
Institutional ownership of Minerva Neurosciences Inc from Form 13F, Q2 2026
58 institutional managers reported holding Minerva Neurosciences Inc (NERV) in Form 13F filings for Q2 2026, with 42,318,900 shares worth $235M. The largest reported holder was Federated Hermes, Inc. Managers that filed both quarters added a net 3,175,382 shares (+9.3%). 22 opened new positions and 8 sold out.
- Funds holding
- 58
- Value held
- $235M
- New / sold out
- 22 / 8
- Net shares, same filers
- +9.3%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of NERV
Share of 13F holdings is each fund's shares as a share of the 42,318,900 NERV shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$9.0M
- Seven Fleet Capital Management LP Added+$4.2M
- Geode Capital Management, LLC Added+$3.5M
- Ally Bridge Group (NY) LLC Added+$2.9M
- State Street Corp Added+$2.0M
- Vanguard Portfolio Management LLC New+$1.3M
- Northern Trust Corp Added+$1.1M
- Goldman Sachs Group Inc Added+$621K
- Charles Schwab Investment Management Inc Added+$459K
- Bank of New York Mellon Corp New+$419K
Biggest sellers in Q2 2026
- DV Trading LLC Sold out-$5.4M
- Federated Hermes, Inc. Trimmed-$2.5M
- Marshall Wace, LLP Sold out-$1.3M
- Millennium Management LLC Trimmed-$970K
- Susquehanna International Group, LLP Sold out-$718K
- Brendel Financial Advisors LLC Sold out-$252K
- Brevan Howard Capital Management LP Sold out-$172K
- UBS Group AG Trimmed-$141K
- Cannon Global Investment Management, LLC Sold out-$107K
- Renaissance Technologies LLC Trimmed-$91K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $28.8M and sold $11.8M; 15 added and 7 trimmed.
Schedule 13D and 13G filings on NERV
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-10-27BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2026-05-15JANUS HENDERSON GROUP PLC SCHEDULE 13G filed by Minerva Neurosciences IncSchedule 13G
- 2026-02-17BALYASNY ASSET MANAGEMENT L.P. SCHEDULE 13G filed by Minerva Neurosciences IncSchedule 13G
- 2026-02-12Adage Capital Management, L.P. SCHEDULE 13G filed by Minerva Neurosciences IncSchedule 13G
- 2025-12-29Farallon Capital Partners, L.P. SCHEDULE 13G filed by Minerva Neurosciences IncSchedule 13G
- 2025-12-29FEDERATED HERMES, INC. SCHEDULE 13G filed by Minerva Neurosciences IncSchedule 13G
- 2025-10-28FEDERATED HERMES, INC. SCHEDULE 13D filed by Minerva Neurosciences IncSchedule 13D
Questions about NERV ownership
- Who owns NERV stock?
- 58 institutional investment managers reported NERV positions in their Form 13F filings for Q2 2026, holding 42,318,900 shares worth $235M in total. Federated Hermes, Inc. reported the largest position.
- Are funds buying or selling NERV?
- In Q2 2026, 22 managers opened new NERV positions, 15 added, 7 trimmed and 8 sold out. Managers that filed in both quarters added a net 3,175,382 shares.
- How current is this NERV institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to NERV by CUSIP. Options are left out. NERV news and filings · NERV insider trades · Top funds